News & Announcements
NIH Initiates Access Planning Efforts within Intramural Research Program
Posted on January 10, 2025March 4, 2025
Share:
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH outlining steps they intend to take to promote patient access to those licensed products. NIH will continue working with industry partners to develop additional resources and guidance in support of these efforts.
For more information see https://osp.od.nih.gov/policies/innovation-and-translation#tab1/
Questions may be sent to SciencePolicy@od.nih.gov
If you are not yet a subscriber to this listserv, please sign up here . Also, please consider following us on X @ NIH_OSP and LinkedIn.
Recent News & Announcements
NIH Releases Draft Policy on Sharing Summary Level Study Results with Clinical Research Participants for Public Comment
August 27, 2026
Research participants are at the heart of the NIH mission...
NIH Releases Draft Biosafety Policy for Research Involving Biohazards for Public Comment
August 19, 2026
Today, NIH has issued a request for public comment on its Draft Biosafety Policy...
White House Releases New U.S. Government Policy for Stopping High-Risk Life Sciences Research
July 28, 2026
Today, the Administration released the U.S. Government Policy for Stopping...